BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 31389810)

  • 1. Graves' hyperthyroidism in pregnancy.
    Nguyen CT; Mestman JH
    Curr Opin Endocrinol Diabetes Obes; 2019 Oct; 26(5):232-240. PubMed ID: 31389810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of hyperthyroidism due to Graves' disease: what is the recommended antithyroid drug during pregnancy?].
    Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2013 May; 42(3):232-7. PubMed ID: 23312275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves' disease.
    McNab T; Ginsberg J
    Clin Invest Med; 2005 Jun; 28(3):127-31. PubMed ID: 16021986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graves'-Basedow disease in pregnancy. New trends in the management and guidance to reduce the risk of birth defects caused by antithyroid drugs.
    Laurberg P; Andersen SL
    Nuklearmedizin; 2015; 54(3):106-11. PubMed ID: 26105719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy.
    Tonacchera M; Chiovato L; Bartalena L; Cavaliere AF; Vitti P
    J Endocrinol Invest; 2020 Feb; 43(2):257-265. PubMed ID: 31784912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of thyrotoxicosis during pregnancy.
    Andersen SL; Knøsgaard L
    Best Pract Res Clin Endocrinol Metab; 2020 Jul; 34(4):101414. PubMed ID: 32199749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Early-Pregnancy Antithyroid Drug Withdrawal in Graves' Disease: A Preliminary Prospective Follow-Up Study.
    Hou X; Guan H; Sun S; Shi Y; Li C; Liu A; Li Y; Gao X; Hou Y; Yang Y; Li Y; Shan Z; Teng W
    Thyroid; 2022 Aug; 32(8):983-989. PubMed ID: 35651276
    [No Abstract]   [Full Text] [Related]  

  • 8. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until Delivery.
    Yoshihara A; Noh JY; Inoue K; Watanabe N; Fukushita M; Matsumoto M; Suzuki N; Suzuki A; Kinoshita A; Yoshimura R; Aida A; Imai H; Hiruma S; Sugino K; Ito K
    Thyroid; 2023 Mar; 33(3):373-379. PubMed ID: 36680759
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithyroid agents and embryopathies].
    Bournaud C; Orgiazzi J
    Ann Endocrinol (Paris); 2003 Nov; 64(5 Pt 1):366-9. PubMed ID: 15067747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' hyperthyroidism in pregnancy: a clinical review.
    Nguyen CT; Sasso EB; Barton L; Mestman JH
    Clin Diabetes Endocrinol; 2018; 4():4. PubMed ID: 29507751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
    Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthyroidism in pregnancy.
    Mestman JH
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):394-401. PubMed ID: 22922367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.
    Žarković M; Wiersinga W; Perros P; Bartalena L; Donati S; Okosieme O; Morris D; Fichter N; Lareida J; Daumerie C; Burlacu MC; Kahaly GJ; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
    J Endocrinol Invest; 2021 Feb; 44(2):371-378. PubMed ID: 32524368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current problems in the treatment of Graves' disease in pregnancy and in lactation].
    Momotani N
    Nihon Rinsho; 2006 Dec; 64(12):2297-302. PubMed ID: 17154095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
    Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
    J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease.
    Washio K; Uenaka M; Tanimura K; Deguchi M; Nishida K; Fujioka K; Yamada H
    Kobe J Med Sci; 2021 Feb; 66(4):E153-E158. PubMed ID: 33994519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' Disease Pharmacotherapy in Women of Reproductive Age.
    Prunty JJ; Heise CD; Chaffin DG
    Pharmacotherapy; 2016 Jan; 36(1):64-83. PubMed ID: 26799350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.